![Todd Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Carter
Directeur Technique/Scientifique/R&D chez
VOYAGER THERAPEUTICS, INC.
Fortune : 563 929 $ au 31/05/2026
Profil
Todd Carter currently works at Voyager Therapeutics, Inc., as Chief Scientific Officer from 2022.
Dr. Carter also formerly worked at BrainCells, Inc., as Senior Director-Biology.
Dr. Carter received his doctorate degree from The Trustees of Columbia University in The City of New York and undergraduate degree from Texas A&M University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/02/2026 | 145 718 ( 0,24 % ) | 563 929 $ | 31/05/2026 |
Postes actifs de Todd Carter
| Sociétés | Poste | Début |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2018 |
Anciens postes connus de Todd Carter
| Sociétés | Poste | Fin |
|---|---|---|
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Formation de Todd Carter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
